These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18688798)

  • 41. LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP.
    Spanaki C; Latsoudis H; Plaitakis A
    Neurology; 2006 Oct; 67(8):1518-9. PubMed ID: 17060595
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
    Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J
    J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.
    Haugarvoll K; Rademakers R; Kachergus JM; Nuytemans K; Ross OA; Gibson JM; Tan EK; Gaig C; Tolosa E; Goldwurm S; Guidi M; Riboldazzi G; Brown L; Walter U; Benecke R; Berg D; Gasser T; Theuns J; Pals P; Cras P; De Deyn PP; Engelborghs S; Pickut B; Uitti RJ; Foroud T; Nichols WC; Hagenah J; Klein C; Samii A; Zabetian CP; Bonifati V; Van Broeckhoven C; Farrer MJ; Wszolek ZK
    Neurology; 2008 Apr; 70(16 Pt 2):1456-60. PubMed ID: 18337586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype.
    Pirkevi C; Lesage S; Condroyer C; Tomiyama H; Hattori N; Ertan S; Brice A; Başak AN
    Neurogenetics; 2009 Jul; 10(3):271-3. PubMed ID: 19172321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Parkinson's disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population.
    Zhou Y; Luo X; Li F; Tian X; Zhu L; Yang Y; Ren Y; Pang H
    J Clin Neurosci; 2012 Jul; 19(7):1011-5. PubMed ID: 22575062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?
    Lesage S; Belarbi S; Troiano A; Condroyer C; Hecham N; Pollak P; Lohman E; Benhassine T; Ysmail-Dahlouk F; Dürr A; Tazir M; Brice A;
    Neurology; 2008 Nov; 71(19):1550-2. PubMed ID: 18981379
    [No Abstract]   [Full Text] [Related]  

  • 47. LRRK2 mutations are uncommon in Turkey.
    Hanagasi HA; Lohmann E; Dursun B; Honoré A; Lesage S; Dogu O; Kaleagasi H; Aydın O; Gürvit H; Erginel-Unaltuna N; Brice A; Emre M
    Eur J Neurol; 2011 Oct; 18(10):e137. PubMed ID: 21914047
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical characteristics of PD patients with LRRK2 G2385R and R1628P variants.
    Liang D; Shu L; Pan H; Xu Q; Guo J; Yan X; Tang B; Sun Q
    Neurosci Lett; 2018 Oct; 685():185-189. PubMed ID: 30121215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.
    Gosal D; Lynch T; Ross OA; Haugarvoll K; Farrer MJ; Gibson JM
    Mov Disord; 2007 Jan; 22(2):291-2. PubMed ID: 17089395
    [No Abstract]   [Full Text] [Related]  

  • 50. Altered intrinsic brain functional connectivity in drug-naïve Parkinson's disease patients with LRRK2 mutations.
    Hou Y; Luo C; Yang J; Ou R; Song W; Chen Y; Gong Q; Shang H
    Neurosci Lett; 2018 May; 675():145-151. PubMed ID: 29567424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LRRK2 mutations and Parkinsonism.
    Toft M; Mata IF; Kachergus JM; Ross OA; Farrer MJ
    Lancet; 2005 Apr 2-8; 365(9466):1229-30. PubMed ID: 15811454
    [No Abstract]   [Full Text] [Related]  

  • 52. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
    Chan DK; Ng PW; Mok V; Yeung J; Fang ZM; Clarke R; Leung E; Wong L
    J Neural Transm (Vienna); 2008 Sep; 115(9):1275-7. PubMed ID: 18523722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.
    Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A
    Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LRRK2 G2019S mutations may be increased in Puerto Ricans.
    Saunders-Pullman R; Cabassa J; San Luciano M; Stanley K; Raymond D; Ozelius LJ; Bressman SB
    Mov Disord; 2011 Aug; 26(9):1772-3. PubMed ID: 21449009
    [No Abstract]   [Full Text] [Related]  

  • 56. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana.
    Cilia R; Sironi F; Akpalu A; Cham M; Sarfo FS; Brambilla T; Bonetti A; Amboni M; Goldwurm S; Pezzoli G
    J Neurol; 2012 Mar; 259(3):569-70. PubMed ID: 21842440
    [No Abstract]   [Full Text] [Related]  

  • 59. LRRK2 P755L variant in sporadic Parkinson's disease.
    Tomiyama H; Mizuta I; Li Y; Funayama M; Yoshino H; Li L; Murata M; Yamamoto M; Kubo SI; Mizuno Y; Toda T; Hattori N
    J Hum Genet; 2008; 53(11-12):1012-1015. PubMed ID: 18923807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LRRK2 A419V is not associated with Parkinson's disease in different Chinese populations.
    Wu YR; Tan LC; Fu X; Chen CM; Au WL; Chen L; Chen YC; Prakash KM; Zheng Y; Lee-Chen GJ; Zhao Y; Zeng JS; Tan EK; Pei Z
    PLoS One; 2012; 7(7):e36123. PubMed ID: 22807999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.